Abstract
Purpose The objective of the present study was to test, in nude mouse PC-3 tumors, the contrast enhancement of 2,4-bis(1-tetrahydro-fulfuroxyethl)-deuteroporphynyl(IX)-6-7-bisaspartic acid (THF-Mn-ASP), which is a hematoporphyrin derivative and depresses T1 relaxation time on magnetic resonance (MR) imaging. Materials and Methods THF-Mn-ASP or gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) was intravenously administered, and MR imaging of the tumors transplanted into nude mice was performed on T1-weighted images. Results After administration of THF-Mn-ASP, the signal intensity of PC-3 tumors increased and the tumor/muscle intensity ratio was highest at about 1 hour. The tumor/muscle intensity ratio, in contrast, was highest at about 5 minutes after administration of Gd-DTPA. The increase in intensity ratio was 32 percent in THF-Mn-ASP and 28 percent in Gd-DTPA. Conclusion The preliminary study suggested that THF-Mn-Asp has a predilection to accumulate in PC-3 tumors, and it seems to provide good contrast enhancement with tumor specificity for MR imaging.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
